Abstract
The development of induced pluripotent stem cells (iPSCs) has shown a great potential in disease modeling, drug screening, organ reconstruction and cancer therapy. Hepatitis C virus (HCV) infection is a leading cause of hepatocellular carcinoma (HCC), particularly in Western countries. However, HCV infection has never been fully understood because the culprit virus only preferably infects human and chimpanzee. Hepatocyte-like cells derived from human iPSCs have been reported to be susceptible to infection with HCV and may serve as an appropriate model for HCV infection. Recently, the field of HCV research has been revolutionized by the finding that pigtail macaque (Macaca nemestrina) hepatic cells derived from iPSCs support the entire HCV life cycle, and pigtail macaques may serve as a suitable, clinically relevant model for the study of HCV infection. Moreover, the technologies generating vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro have also been established. These findings will play a very important role in understanding the mechanism of HCV infection and therapy for HCV related HCC.
Keywords: Disease modeling, hepatitis C virus, hepatocellular carcinoma, induced pluripotent stem cells, iPSCs, liver transplantation.
Current Stem Cell Research & Therapy
Title:Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection
Volume: 10 Issue: 3
Author(s): Lin Cheng, Yong Zhang, Yuemin Nan and Liang Qiao
Affiliation:
Keywords: Disease modeling, hepatitis C virus, hepatocellular carcinoma, induced pluripotent stem cells, iPSCs, liver transplantation.
Abstract: The development of induced pluripotent stem cells (iPSCs) has shown a great potential in disease modeling, drug screening, organ reconstruction and cancer therapy. Hepatitis C virus (HCV) infection is a leading cause of hepatocellular carcinoma (HCC), particularly in Western countries. However, HCV infection has never been fully understood because the culprit virus only preferably infects human and chimpanzee. Hepatocyte-like cells derived from human iPSCs have been reported to be susceptible to infection with HCV and may serve as an appropriate model for HCV infection. Recently, the field of HCV research has been revolutionized by the finding that pigtail macaque (Macaca nemestrina) hepatic cells derived from iPSCs support the entire HCV life cycle, and pigtail macaques may serve as a suitable, clinically relevant model for the study of HCV infection. Moreover, the technologies generating vascularized and functional human liver from human iPSCs by transplantation of liver buds created in vitro have also been established. These findings will play a very important role in understanding the mechanism of HCV infection and therapy for HCV related HCC.
Export Options
About this article
Cite this article as:
Cheng Lin, Zhang Yong, Nan Yuemin and Qiao Liang, Induced Pluripotent Stem Cells (iPSCs) in the Modeling of Hepatitis C Virus Infection, Current Stem Cell Research & Therapy 2015; 10 (3) . https://dx.doi.org/10.2174/1574888X09666140923121234
DOI https://dx.doi.org/10.2174/1574888X09666140923121234 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Potential Health Benefits of Algae and Micro Algae in Medicine: A Review on Spirulina platensis
Current Nutrition & Food Science An Evolving Role of Piperazine Moieties in Drug Design and Discovery
Mini-Reviews in Medicinal Chemistry MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets The Digenea Parasite Opisthorchis felineus: A Target for the Discovery and Development of Novel Drugs
Infectious Disorders - Drug Targets Proteomic Approaches for the Study of Transgelins as Tumor-associated Proteins and Potential Biomarkers
Current Proteomics Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry Can microRNAs be Biomarkers or Targets for Therapy of Ischemic Coronary Artery Disease in Metabolic Syndrome?
Current Drug Targets Ligand-Dependent Assembly of Pregnane X Receptor, Constitutive Androstane Receptor and Liver X Receptor Is Applicable to Identify Ligands
Drug Metabolism Letters Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Current Medicinal Chemistry - Anti-Cancer Agents Effects of Oxymatrine from Ku Shen on Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Role of α7-Nicotinic Acetylcholine Receptor in Normal and Cancer Stem Cells
Current Drug Targets Epigenetic Alterations of the Wnt/β -Catenin Pathway in Human Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors
Current Pharmaceutical Design Runx1/AML1 is a Guardian of Hematopoietic Stem Cells
Current Cancer Therapy Reviews Unravelling the Role of Infectious Agents in the Pathogenesis of Human Autoimmunity: The Hypothesis of the Retroviral Involvement Revisited
Current Molecular Medicine Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Current Medicinal Chemistry Pluripotent Stem Cells for Livestock Health and Production
Current Stem Cell Research & Therapy Natural DNA Intercalators as Promising Therapeutics for Cancer and Infectious Diseases
Current Cancer Drug Targets Influence of Impaired Liver Methionine Metabolism on the Development of Vascular Disease and Inflammation
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Glycerophospholipid Synthesis as a Novel Drug Target Against Cancer
Current Molecular Pharmacology